Homepage
Author:
Acumen Pharmaceuticals, Inc.
Posted Date:
March 26, 2026
Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2025 and Business Highlights
Acumen Pharmaceuticals, Inc.
March 26, 2026
Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2025 Financial Results on March 26, 2026
Acumen Pharmaceuticals, Inc.
March 19, 2026
Acumen Pharmaceuticals Presents Studies on Enhanced Brain Delivery™, Biomarker Research, and Novel Antibodies at Advances in Alzheimer’s Treatment at International Conference on Alzheimer’s and Parkinson’s Diseases 2026
Acumen Pharmaceuticals, Inc.
March 17, 2026
Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio
Acumen Pharmaceuticals, Inc.
March 16, 2026
Acumen Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum
Acumen Pharmaceuticals, Inc.
March 10, 2026
Acumen Pharmaceuticals to Showcase Advances in Alzheimer’s Treatment at International Conference on Alzheimer’s and Parkinson’s Diseases 2026
Acumen Pharmaceuticals, Inc.
March 3, 2026
